Dr Reddy's Laboratories Ltd
Company Profile
Business description
Dr. Reddy’s is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy’s also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy’s has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy’s also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Contact
8-2-337, Road No. 3
Banjara Hills
HyderabadTG500 034
INDT: +91 4049002900
E: shares@drreddys.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
27,048
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,422.10 | 17.40 | -0.21% |
CAC 40 | 7,350.37 | 77.99 | -1.05% |
DAX 40 | 19,077.54 | 179.80 | -0.93% |
Dow JONES (US) | 41,763.46 | 378.08 | -0.90% |
FTSE 100 | 8,110.10 | 49.53 | -0.61% |
HKSE | 20,317.33 | 63.31 | -0.31% |
NASDAQ | 18,095.15 | 512.78 | -2.76% |
Nikkei 225 | 39,081.25 | 196.14 | -0.50% |
NZX 50 Index | 12,580.80 | 58.10 | -0.46% |
S&P 500 | 5,705.45 | 108.22 | -1.86% |
S&P/ASX 200 | 8,160.00 | 20.40 | -0.25% |
SSE Composite Index | 3,279.82 | 13.59 | 0.42% |